Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 10:10 PM
Ignite Modification Date: 2025-12-25 @ 7:46 PM
NCT ID: NCT01696435
Description: Results for adverse events are reported by each of the 4 factorial arms of the trial.
Frequency Threshold: 0
Time Frame: Adverse event data were collected over the entire randomized treatment and follow-up period, which was a median of 5.3 years. VITAL-DEP is an ancillary study of the VITAL trial. For total adverse events reported by the parent VITAL trial, please see Results reported by VITAL, NCT01169259.
Study: NCT01696435
Study Brief: VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Vitamin D + Fish Oil Placebo Vitamin D: Vitamin D3 (cholecalciferol), 2000 IU per day Fish oil placebo: Fish oil placebo, one capsule per day 153 None 545 4573 2803 4573 View
Vitamin D Placebo + Fish Oil Vitamin D placebo: Vitamin D3 placebo, one capsule per day Fish oil: Omacor, one capsule per day. Each capsule of Omacor contains 840 milligrams of marine omega-3 fatty acids (465 mg of eicosapentaenoic acid \[EPA\] and 375 mg of docosahexaenoic acid \[DHA\]) 152 None 569 4563 2789 4563 View
Vitamin D + Fish Oil Vitamin D: Vitamin D3 (cholecalciferol), 2000 IU per day Fish oil: Omacor, one capsule per day. Each capsule of Omacor contains 840 milligrams of marine omega-3 fatty acids (465 mg of eicosapentaenoic acid \[EPA\] and 375 mg of docosahexaenoic acid \[DHA\]) 153 None 549 4608 2825 4608 View
Vitamin D Placebo + Fish Oil Placebo Vitamin D placebo: Vitamin D3 placebo, one capsule per day Fish oil placebo: Fish oil placebo, one capsule per day 133 None 570 4609 2876 4609 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Major cardiovascular event SYSTEMATIC_ASSESSMENT Vascular disorders None View
Invasive cancer of any type SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) None View
Gastrointestinal Bleeding SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Hypercalcemia SYSTEMATIC_ASSESSMENT Endocrine disorders None View
Suicide SYSTEMATIC_ASSESSMENT Psychiatric disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Hyperparathyroidism or parathyroid condition SYSTEMATIC_ASSESSMENT Endocrine disorders None View
Kidney stones SYSTEMATIC_ASSESSMENT Renal and urinary disorders None View
Kidney failure SYSTEMATIC_ASSESSMENT Renal and urinary disorders None View
Hematuria SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Easy bruising SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Frequent nosebleeds SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Stomach upset or pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Skin rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View